Literature DB >> 10987849

Effect of transient focal ischemia of mouse brain on energy state and NAD levels: no evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism.

W Paschen1, L Oláh, G Mies.   

Abstract

It has been proposed that NAD depletion resulting from excessive activation of poly(ADP-ribose) polymerase is responsible for secondary energy failure after transient cerebral ischemia. However, this hypothesis has never been verified by measurement of ATP and NAD levels in the same tissue sample. In this study, we therefore investigated the effect of transient focal cerebral ischemia on the temporal profiles of changes in the levels of energy metabolites and NAD. Ischemia was induced in mice by occluding the left middle cerebral artery using the intraluminal filament technique. Animals were subjected to 1-h ischemia, followed by 0, 1, 3, 6, or 24 h of reperfusion. During ischemia, ATP levels, total adenylate pool, and adenylate energy charge dropped to approximately 20, 50, and 40% of control, respectively, whereas NAD levels remained close to control. Energy state recovered transiently, peaking at 3 h of recovery (ATP levels and total adenylate pool recovered to 78 and 81% of control). In animals subjected to reperfusion of varying duration, the extent of ATP depletion was clearly more pronounced than that of NAD. The results imply that depletion of NAD pools did not play a major role in secondary disturbances of energy-producing metabolism after transient focal cerebral ischemia. Changes in ATP levels were closely related to changes in total adenylate pool (p<0.001). The high energy charge after 6 h of reperfusion (0.90 versus a control value of 0.93) and the close relationship between the decline of ATP and total adenylate pool suggest that degradation or a washout of adenylates (owing to leaky membranes) rather than a mismatch between energy production and consumption is the main causative factor contributing to the secondary energy failure observed after prolonged recovery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987849     DOI: 10.1046/j.1471-4159.2000.0751675.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death.

Authors:  Conrad C Alano; Philippe Garnier; Weihai Ying; Youichirou Higashi; Tiina M Kauppinen; Raymond A Swanson
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

2.  Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis.

Authors:  Shaida A Andrabi; George K E Umanah; Calvin Chang; Daniel A Stevens; Senthilkumar S Karuppagounder; Jean-Philippe Gagné; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-01       Impact factor: 11.205

3.  Down-regulation of parkin protein in transient focal cerebral ischemia: A link between stroke and degenerative disease?

Authors:  Thorsten Mengesdorf; Poul H Jensen; Gunter Mies; Christoph Aufenberg; Wulf Paschen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

4.  Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death.

Authors:  Robert P Strosznajder; Roman Gadamski; Grzegorz A Czapski; Henryk Jesko; Joanna B Strosznajder
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

5.  The Continued Promise of Neuroprotection for Acute Stroke Treatment.

Authors:  Shimin Liu; Steven R Levine
Journal:  J Exp Stroke Transl Med       Date:  2008

Review 6.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

7.  Nicotinamide attenuates focal ischemic brain injury in rats: with special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra.

Authors:  Fumiko Sadanaga-Akiyoshi; Hiroshi Yao; Sei-ichi Tanuma; Tatsuo Nakahara; Jong Soon Hong; Setsuro Ibayashi; Hideyuki Uchimura; Masatoshi Fujishima
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

8.  PARP-1 inhibits glycolysis in ischemic kidneys.

Authors:  Kishor Devalaraja-Narashimha; Babu J Padanilam
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

9.  Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia.

Authors:  Pavan K Shetty; Francesca Galeffi; Dennis A Turner
Journal:  Neurobiol Dis       Date:  2013-10-31       Impact factor: 5.996

Review 10.  Parthanatos, a messenger of death.

Authors:  Karen Kate David; Shaida Ahmad Andrabi; Ted Murray Dawson; Valina Lynn Dawson
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.